Main > ONCOLOGY (**) > Sarcoma>Kaposi s Sarcoma>AIDS*** > Treatment > USA. J. DoxoRubicin Liposome>



USA. J. DoxoRubicin Liposome>'s subsections
Approved
Company
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 2
Patent>USA Expiration: 2020. 04.21
TradeMark
TradeMark Web-Site

USA. J. DoxoRubicin Liposome>'s products
This section has no products